EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Complex Role of Gut Microbiota in Systemic Lupus Erythematosus and Lupus Nephritis: From Pathogenetic Factor to Therapeutic Target

Emanuele Parodi iD, Marialuisa Novi, Paolo Bottino iD, Edoardo La Porta, Guido Merlotti iD, Luigi Mario Castello iD, Franca Gotta, Andrea Rocchetti, Marco Quaglia iD

Microorganisms · 18.02.2025 · 13 (2) · 445

DOI: 10.3390/microorganisms13020445 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 18.02.2025. Verfasst von Emanuele Parodi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology and Dialysis Unit, SS. Antonio e Biagio e Cesare Arrigo University Hospital, 15121 Alessandria, Italy. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The role of gut microbiota (GM) and intestinal dysbiosis in triggering the onset and/or modulating the severity and progression of lupus nephritis (LN) has been the object of intense research over the last few years. Some alterations at the phyla level, such as the abundance of Proteobacteria and reduction in Firmicutes/Bacteroidetes (F/B) ratio and in α-diversity have been consistently reported in systemic lupus erythematosus (SLE), whereas a more specific role has been ascribed to some species (Bacteroides thetaiotaomicron and Ruminococcus gnavus) in LN. Underlying mechanisms include microbial translocation through a “leaky gut” and subsequent molecular mimicry, immune dysregulation (alteration of IFNγ levels and of balance between Treg and Th17 subsets), and epigenetic interactions. Levels of bacterial metabolites, such as butyrate and other short-chain fatty acids (SCFAs), appear to play a key role in modulating LN. Beyond bacterial components of GM, virome and mycobiome are also increasingly recognized as important players in the modulation of an immune response. On the other hand, microbiota-based therapy appears promising and includes diet, prebiotics, probiotics, symbiotics, and fecal microbiota transplantation (FMT). The modulation of microbiota could correct critical alterations, such as F/B ratio and Treg/Th17 imbalance, and blunt production of autoantibodies and renal damage. Despite current limits, GM is emerging as a powerful environmental factor that could be harnessed to interfere with key mechanisms leading to SLE, preventing flares and organ damage, including LN. The aim of this review is to provide a state-of-the-art analysis of the role of GM in triggering and modulating SLE and LN on the one hand, while exploring possible therapeutic manipulation of GM to control the disease on the other hand.

Schlagwörter

Stichwörter der Autor:innen

autoimmunitydysbiosisfecal microbiota transplantgut microbiotalupus nephritisprobioticsystemic lupus erythematosus

Autor:innen und Institutionen

  • Nephrology and Dialysis Unit, SS. Antonio e Biagio e Cesare Arrigo University Hospital, 15121 Alessandria, Italy.
  • Gastroenterology Unit, SS. Antonio e Biagio e Cesare Arrigo University Hospital, 15121 Alessandria, Italy.
  • Microbiology Unit, SS. Antonio e Biagio e Cesare Arrigo University Hospital, 15121 Alessandria, Italy.
  • Nephrology and Dialysis Unit, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.
  • Department of Primary Care, Azienda Socio Sanitaria Territoriale (ASST) of Pavia, 27100 Pavia, Italy.
  • Internal Medicine Unit, SS. Antonio e Biagio e Cesare Arrigo University Hospital, 15121 Alessandria, Italy.

ORCID-Profile: Emanuele Parodi, Paolo Bottino, Guido Merlotti, Luigi Mario Castello, Marco Quaglia

Zitieren

APA

Parodi, E., Novi, M., Bottino, P., La Porta, E., Merlotti, G., Castello, L. M., Gotta, F., Rocchetti, A., & Quaglia, M. (2025). The Complex Role of Gut Microbiota in Systemic Lupus Erythematosus and Lupus Nephritis: From Pathogenetic Factor to Therapeutic Target. Microorganisms, 13(2), 445. https://doi.org/10.3390/microorganisms13020445

Vancouver

Parodi E, Novi M, Bottino P, La Porta E, Merlotti G, Castello LM, et al. The Complex Role of Gut Microbiota in Systemic Lupus Erythematosus and Lupus Nephritis: From Pathogenetic Factor to Therapeutic Target. Microorganisms. 2025;13(2):445. doi:10.3390/microorganisms13020445

BibTeX
@article{Parodi2025,
  author = {Parodi, Emanuele and Novi, Marialuisa and Bottino, Paolo and La Porta, Edoardo and Merlotti, Guido and Castello, Luigi Mario and Gotta, Franca and Rocchetti, Andrea and Quaglia, Marco},
  title = {The Complex Role of Gut Microbiota in Systemic Lupus Erythematosus and Lupus Nephritis: From Pathogenetic Factor to Therapeutic Target},
  journal = {Microorganisms},
  year = {2025},
  volume = {13},
  number = {2},
  pages = {445},
  doi = {10.3390/microorganisms13020445}
}
Kostenlos starten →